"Not long ago, younger patients received the most aggressive CLL treatment, which gave them the greatest chance for long-term disease control, and elderly patients were given less-effective palliative care. Now therapies are targeted, have fewer side effects and are suitable for the older patient, giving them the same chance of a longer life. Dr. Valentin Goede, a hematologist/oncologist and gerontologist who specializes in CLL care at the University of Cologne in Germany, explains how this is a much more positive time for elderly people with CLL."
patientpower.info/video/pos...
Usual rider applies about availability of access to new therapies, but if you are elderly and your time for treatment is approaching, make certain that you investigate what clinical trials may be available to you.
Neil
Another CLL patient dies disease free from complications of her treatment.
